Welcome to our dedicated page for CompoSecure news (Ticker: $CMPO), a resource for investors and traders seeking the latest updates and insights on CompoSecure stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CompoSecure's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CompoSecure's position in the market.
CompoSecure, Inc. (Nasdaq: CMPO) reported record first-quarter 2024 financial results, with Q1 net sales up 9% to $104.0 million, net income up 59% to $17.1 million, and adjusted EBITDA up 6% to $37.8 million. The company declared a special cash dividend of $0.30 per share, reflecting a strong start in 2024 driven by domestic business momentum and high-profile customer programs. CompoSecure ended the quarter with a cash balance of $55 million, doubled from a year ago. Operational highlights include strong domestic growth, new card programs, and product enhancements. The company's liquidity and capital structure remained strong, with $55.1 million in cash and cash equivalents and a secured debt leverage ratio of 1.34x at March 31, 2024. Overall, CompoSecure's financial outlook for 2024 remains positive, reiterating full-year guidance for net sales between $408-$428 million and adjusted EBITDA between $147-$157 million.